Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now shows Revision: v3.5.3. This indicates an updated revision of the study documents.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.5.2 has been added to the page, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 is now shown and prior revision notices (v3.4.1) as well as the government funding status notice are no longer displayed. These maintenance-related changes do not affect the study details or how users interact with the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedA site-wide government funding notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.